SNW(SH:600628) Shang Hai Zheng Quan Bao·2025-11-21 18:46Core Viewpoint - The company has decided to continue using raised funds to purchase wealth management products or structured deposits, aiming to enhance fund utilization efficiency while ensuring that it does not affect the construction of investment projects or the use of raised funds [1][15]. Summary by Sections 1. Basic Situation of Raised Funds - The company raised a total of 1,315,319,983.02 RMB through a non-public offering of 115,076,114 shares at a price of 11.43 RMB per share, with a net amount of 1,303,670,100.75 RMB after deducting various fees [1]. 2. Management and Use of Raised Funds - The company has established a special account for the management of raised funds, ensuring that all funds are stored in a dedicated account approved by the board of directors [2]. 3. Investment Project Details - The company has adjusted its investment projects, reallocating funds from certain health industry projects to invest 45,800.58 million RMB in the construction of a traditional Chinese medicine production base [4]. 4. Previous Use of Idle Raised Funds - The company has previously approved the use of idle raised funds for wealth management products or structured deposits, with limits set at various amounts over the years, including 10 billion RMB and 13 billion RMB in different meetings [5][6]. 5. Current Investment Plan - The company plans to use up to 850 million RMB of idle raised funds for purchasing wealth management products or structured deposits, ensuring that these investments are safe, liquid, and have a capital protection commitment [11][15]. 6. Risk Control Measures - The company will select financial institutions that can provide capital protection and ensure high safety and liquidity for the investment products, with independent directors and the audit committee having oversight rights [16]. 7. Impact on the Company - The investment in low-risk short-term wealth management products is expected to enhance fund utilization efficiency and provide additional returns to shareholders without negatively impacting the company's main business operations [18]. 8. Sponsor Institution's Opinion - The sponsor institution has confirmed that the decision to continue using raised funds for wealth management products has followed necessary approval procedures and complies with relevant regulations [18].